Complications of Sleep Apnea

Cardiovascular Complications - Heart Under Pressure

OSA chronically stresses the heart via intermittent hypoxia/hypercapnia, sympathetic overdrive, oxidative stress, and systemic inflammation.

• Hypertension:
  • Systemic: OSA is a key secondary cause; often treatment-resistant. Prevalence: 30-70% in OSA.
  • Pulmonary: Due to hypoxic vasoconstriction; can lead to Cor Pulmonale (Right Heart Failure).
• Coronary Artery Disease (CAD):
  • ↑ Risk of angina, Myocardial Infarction (MI), especially nocturnal.
  • Mechanisms: Endothelial dysfunction, pro-inflammatory state, pro-thrombotic state.
• Cardiac Arrhythmias:
  • Atrial Fibrillation (AF): Most common; OSA ↑ recurrence post-ablation.
  • Bradyarrhythmias: Sinus bradycardia, AV blocks during apneic events.
  • Ventricular Tachycardia/Fibrillation: ↑ Risk of Sudden Cardiac Death (SCD), particularly during sleep.
• Heart Failure (HF):
  • Both Left Ventricular (LV) systolic & diastolic dysfunction.
  • OSA can worsen pre-existing HF and contribute to new-onset HF.
• Cerebrovascular Accidents (CVA):
  • ↑ Risk of Stroke and Transient Ischemic Attacks (TIA).
  • Associated with AF, hypertension, and accelerated atherosclerosis.

⭐ Patients with OSA have a 2-4 fold increased risk of developing hypertension compared to the general population.

Neurocognitive & Metabolic Issues - Mind & Metabolism

• Neurocognitive Manifestations:
  • Persistent daytime hypersomnolence, overwhelming fatigue.
  • Cognitive deficits: impaired attention span, poor concentration, memory lapses (short-term), compromised executive functions (planning, decision-making).
  • Mood disturbances: increased incidence of depression, anxiety disorders, irritability.
  • Characteristic morning headaches.
  • Significantly ↑ risk of motor vehicle accidents (MVA) & workplace injuries.
  • Overall ↓ quality of life.
• Metabolic Dysregulation:
  • Insulin Resistance: Key factor, significantly ↑ risk for Type 2 Diabetes Mellitus.
  • Dyslipidemia: Characterized by ↑ triglycerides (TG) & ↓ High-Density Lipoprotein (HDL) cholesterol.
  • Metabolic Syndrome: OSA is a strong independent risk factor; clustering of (central obesity, HTN, dyslipidemia, IR).
  • Non-Alcoholic Fatty Liver Disease (NAFLD) & Non-Alcoholic Steatohepatitis (NASH): common comorbidities.
  • Chronic low-grade systemic inflammation: evidenced by ↑ C-Reactive Protein (CRP), IL-6.
  • Hyperuricemia: may contribute to ↑ gout incidence.

⭐ Patients with moderate to severe OSA have a significantly higher likelihood of developing insulin resistance and subsequent Type 2 Diabetes, independent of obesity.

Other Systemic Effects - Beyond Heart & Head

• Gastrointestinal:
  • ↑ GERD: Negative intrathoracic pressure promotes nocturnal acid reflux.
  • NAFLD (Non-alcoholic Fatty Liver Disease): OSA = independent risk; linked to intermittent hypoxia, systemic inflammation.
• Renal:
  • Nocturnal Polyuria: ↑ ANP (hypoxemia, intrathoracic pressure changes), ↓ ADH effect.
  • CKD progression: Worsened by chronic hypoxia, sympathetic activation, inflammation.
• Endocrine:
  • ↓ Growth Hormone (GH) secretion: Disrupted slow-wave sleep impairs pulsatile release.
• Hematological:
  • Secondary Polycythemia: Chronic hypoxemia stimulates erythropoietin.
  • Hypercoagulability: Endothelial dysfunction, ↑ platelet activation, ↑ fibrinogen.
• Ophthalmological:
  • NAION (Non-arteritic Anterior Ischemic Optic Neuropathy): Strong association.
  • Floppy Eyelid Syndrome (FES): Common co-morbidity.
  • ↑ Glaucoma risk (Open-angle, Normal Tension).
• Perioperative:
  • Increased risk: difficult intubation, airway obstruction.
  • Higher post-op risk: respiratory depression, atelectasis, hypoxemia.
• Other:
  • Erectile Dysfunction: Common; hypoxia, endothelial dysfunction, autonomic dysregulation.
  • Sensorineural Hearing Loss: Potential link via cochlear hypoxia.

⭐ OSA is a key risk factor for Non-arteritic Anterior Ischemic Optic Neuropathy (NAION), causing sudden, painless, monocular vision loss, often on waking.

High-Yield Points - ⚡ Biggest Takeaways

• Systemic hypertension is a primary cardiovascular risk; pulmonary hypertension also occurs.
• Increased risk of cardiac arrhythmias (e.g., AF), myocardial infarction (MI), and stroke.
• Strong association with insulin resistance, increasing Type 2 Diabetes Mellitus risk.
• Neurocognitive impacts: excessive daytime somnolence, impaired concentration, mood changes.
• Higher perioperative complication rates and increased risk of motor vehicle accidents.
• Linked to Non-Alcoholic Fatty Liver Disease (NAFLD) and can worsen GERD.
• Untreated OSA significantly elevates all-cause mortality.